{
    "title": "Individual feed for https://khn.org/feed",
    "link": "https://khn.org/feed",
    "description": "Individual feed output.",
    "lastBuildDate": "2026-01-22T07:52:43.535184",
    "items": [
        {
            "title": "Make Us Swoon: Send In Your Health Policy Valentines",
            "link": "https://kffhealthnews.org/news/article/health-policy-valentines-annual-contest/",
            "description": "Affordable health care is our love language. We want to see your most clever, heartfelt, or hilarious tributes to the policies that shape health care....",
            "pubDate": "2026-01-22T10:00:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Farmers Now Owe a Lot More for Health Insurance",
            "link": "https://kffhealthnews.org/news/article/farmers-health-insurance-costs-aca-obamacare-subsidies/",
            "description": "More than a quarter of the agricultural workforce purchases health insurance through the individual marketplace, a much larger share than the overall ...",
            "pubDate": "2026-01-22T10:00:00",
            "image_url": "https://kffhealthnews.org/wp-content/uploads/sites/2/2026/01/Palmer-Farm.jpg"
        },
        {
            "title": "As US Is Poised To Lose Measles-Free Status, RFK Jr.’s New CDC Deputy Downplays Its Significance",
            "link": "https://kffhealthnews.org/news/article/measles-free-status-us-cdc-ralph-abraham-paho-who-outbreaks-vaccines/",
            "description": "Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.",
            "pubDate": "2026-01-21T20:38:49",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work",
            "link": "https://kffhealthnews.org/news/article/sickle-cell-disease-gene-therapy-medicaid-vertex-bluebird-bio/",
            "description": "The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments o...",
            "pubDate": "2026-01-21T10:00:00",
            "image_url": "https://kffhealthnews.org/wp-content/uploads/sites/2/2026/01/Sickle-cell-drugs-01-lo.jpg"
        },
        {
            "title": "Los pagos de Medicaid por el tratamiento de la anemia falciforme dependerán de su éxito",
            "link": "https://kffhealthnews.org/news/article/los-pagos-de-medicaid-por-el-tratamiento-de-la-anemia-falciforme-dependeran-de-su-exito/",
            "description": "Actualmente hay dos terapias génicas aprobadas por la FDA, con costos de $2,2 millones por paciente en un caso y $3,1 millones en el otro, sin incluir...",
            "pubDate": "2026-01-21T10:00:00",
            "image_url": "https://kffhealthnews.org/wp-content/uploads/sites/2/2026/01/Sickle-cell-drugs-01-lo.jpg"
        }
    ]
}